Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Idaho gains rights to PCR (polymerase chain reaction) technology from Roche

This article was originally published in Clinica

Executive Summary

Idaho Technologies, a Salt Lake City, Utah-based developer of thermocycling technology for polymerase chain reaction (PCR) experiments, has gained non-exclusive, worldwide rights to patents covering PCR owned by Roche Diagnostics, enabling it to make, use and sell products using PCR for in vitro diagnostics. Idaho's developments of thermocycling instrumentation include its own RAPID and RAZOR instruments, as well as the LightCycler system, developed and produced for Basel, Switzerland-based Roche.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT054085

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel